Literature DB >> 6476919

Employment in ankylosing spondylitis.

L E McGuigan, H H Hart, P J Gow, B L Kidd, R R Grigor, T E Moore.   

Abstract

All patients with ankylosing spondylitis attending our rheumatology clinics were reviewed to assess the effect of their disease on employment. Back movement was measured in three planes, chest expansion determined, and peripheral joint involvement was noted to see whether these correlated with work capability. Sixty patients were reviewed (47 men, 13 women; mean disease duration 24.3 years). Nine were unemployed, but only four of these attributed this condition to ankylosing spondylitis. Although all four had severe neck, back, and hip involvement, this did not differentiate them from other patients who were fully employed. There was no relationship between disease duration and employment. The prospect for continued employment in ankylosing spondylitis is good even when the disease is long standing and severe.

Entities:  

Mesh:

Year:  1984        PMID: 6476919      PMCID: PMC1001418          DOI: 10.1136/ard.43.4.604

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  7 in total

1.  Clinical features and course of ankylosing spondylitis; as seen in a follow-up of 222 hospital referred cases.

Authors:  M WILKINSON; E G BYWATERS
Journal:  Ann Rheum Dis       Date:  1958-06       Impact factor: 19.103

2.  The natural history of rheumatoid spondylitis.

Authors:  B BLUMBERG; C RAGAN
Journal:  Medicine (Baltimore)       Date:  1956-02       Impact factor: 1.889

3.  An objective clinical method to measure spinal extension.

Authors:  J M Moll; S P Liyanage; V Wright
Journal:  Rheumatol Phys Med       Date:  1972-05

4.  Measurement of back movement.

Authors:  I F Macrae; V Wright
Journal:  Ann Rheum Dis       Date:  1969-11       Impact factor: 19.103

5.  Normal range of spinal mobility. An objective clinical study.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1971-07       Impact factor: 19.103

6.  Assessment of longterm benefit of total hip replacement in patients with ankylosing spondylitis.

Authors:  W R Shanahan; R E Kaprove; P A Major; T Hunter; F D Baragar
Journal:  J Rheumatol       Date:  1982 Jan-Feb       Impact factor: 4.666

7.  An objective clinical study of chest expansion.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1972-01       Impact factor: 19.103

  7 in total
  4 in total

1.  Employment perspectives of patients with ankylosing spondylitis.

Authors:  A M J Chorus; A Boonen; H S Miedema; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

2.  Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients.

Authors:  A Boonen; A Chorus; H Miedema; D van der Heijde; H van der Tempel; S van der Linden
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

3.  HLA-B27 associated cross-reactive marker on the cells of New Zealand patients with ankylosing spondylitis.

Authors:  L E McGuigan; A F Geczy; J K Prendergast; J P Edmonds; H H Hart; H V Bashir
Journal:  Ann Rheum Dis       Date:  1986-02       Impact factor: 19.103

4.  Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic.

Authors:  S Forejtová; H Mann; J Stolfa; K Vedral; I Fenclová; D Némethová; K Pavelka
Journal:  Clin Rheumatol       Date:  2008-02-05       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.